The anatomic pathology market size is estimated to be USD 38,432.1 million in 2022 and is expected to witness a CAGR of 7.25% during the forecast period 2023-2033. Rise in the clinical use of biomarkers, increasing reliance on pathology tests, numerous joint ventures and partnerships with top companies for the introduction of an efficient portfolio are factors contributing to the market growth. Furthermore, major companies are implementing a number of strategic activities to create upgraded and improved pathology devices is expected to propel the market. However, lack of skilled workforce and existence of refurbished anatomic pathology systems is expected to hinder the growth.

Major companies are implementing a number of strategic activities to create upgraded and improved pathology devices is predicted to fuel the market. For instance, Leica Biosystems and Paige, an AI-based company, announced a strategic partnership agreement in April 2021 to develop computational pathology technologies. This strategic move was made by the company to broaden its offering of digital pathology products. In a similar vein, Quest Diagnostics and Paige announced their collaboration to create AI-based cancer pathology products in May 2021.

Numerous joint ventures and partnerships with top companies for the introduction of an efficient portfolio is projected to spur the market growth. For instance, to increase the use of AI-based digital pathology, Royal Philips partnered with Ibex Medical Analytics in April 2021, a company engaged in AI-based cancer diagnosis. Both companies merged their knowledge to provide cutting-edge pathologists with solutions.

Segmentation

By Product & Service

The market is categorized into consumables, instruments, and service. In 2022, the consumables segment accounted for the highest revenue share due to the availability of a broad range of products and a high rate of consumable usage. The anatomic pathology techniques are supported by a sizable industry of reagents and kits, antibodies, and probes. A few important reagents and kits are Tamping Tools Kits, CISH Centromere Detection Kits by Thermo Fisher, Ultra View SISH DNP Detection Kit, ISH iVIEW Blue Plus Detection Kit by Roche, and Instrument Cleaning Kit by Agilent. Ongoing technological developments and concentrated efforts by market players to provide anatomic pathological instruments with a better design are projected to support the growth of the instruments sector. However, one cryostat CF-6100, was introduced by Precisionary Instruments in April 2020. In pathology, histology, and dermatology, this cryostat aids and encourages tissue sectioning.

 By Application

The market is categorized into drug discovery & development, disease diagnosis, and others. In the global market, the disease diagnosis segment accounted for the largest revenue share in 2022 owing to increasing prevalence of chronic diseases such as cancer and the growing elderly population. The anatomic pathology workflow helps with tumour diagnosis while stromal cells are actively inflaming and proliferating, which lowers the cost of tumour removal. The advent of unique and inventive diagnostics techniques is another factor that is accelerating the segment’s expansion. The drug discovery and development segment is anticipated to expand at a profitable rate over the projected period. In order to assess the negative effects of potential medications, anatomic pathology is a critical component of toxicological assessment.

By End User

The market is segmented into research laboratories, hospitals, diagnostic laboratories, and others. In 2022, the hospitals segment accounted for the largest revenue share owing to high hospitalisation rate of cancer patients and the rising prevalence of frequent readmissions in hospitals. Additionally, the existence of a well-developed infrastructure and a skilled staff in pathological laboratories located in hospitals boosts the expansion of the hospital segment. Furthermore, it is anticipated that the hospital sector would benefit from an increase in the number of projects launched by public and private organisations to support cutting-edge healthcare systems. The diagnostic laboratories market has experienced profitable growth as a result of the development of cutting-edge testing methodologies and equipment.

Regional Markets

In 2022, North America region accounted for the highest revenue in the anatomic pathology market and is expected to maintain its dominance during the forecast period. This is attributed to the existence of well-known players, expanding use of enhanced imaging techniques in digital pathology services, increasing public awareness of routine health screenings, and advantageous government reimbursement regulations. The U.S. market gains dominance as a result of significant firms’ efforts to maintain their share. For instance, Agilent Technologies established a strategic partnership with Visiopharm in September 2021 in order to globalise their artificial intelligence (AI) powered precision pathology software. These collaborations are expected to support market expansion.

Competitor Insights

Some of the key players operating in the anatomic pathology market are NeoGenomics Laboratories, Inc., Quest Diagnostics Incorporated, PHC Holdings Corporation, Cardinal Health, Agilent Technologies, Inc., BioGenex, Laboratory Corporation of America Holdings, Danaher Corporation, F. Hoffmann-La Roche AG, Sakura Finetek USA, Inc., and Bio SB

To achieve a competitive edge, these businesses are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

For instance, Roche announced the launch of the open environment for digital pathology in September 2021. Researchers and doctors share photos for improved analysis due to the new process. The platform also supports whole-slide imaging technologies.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product & service, application, and end user from 2023 to 2033.

Report Scope:

Segmentation: Anatomic Pathology Market Report 2022 – 2033

Product & Service (Revenue, USD Million), 2022 – 2033

• Consumables
  • Automatic Stainers
  • Microtome & Cryostat
  • Tissue Processors
  • Whole Slide Imaging (WSI)
  • Others
• Instruments
  • Probe & Kits
  • Reagents & Antibodies
  • Others
• Service

Application (Revenue, USD Million), 2022 – 2033

• Drug Discovery & Development
• Disease Diagnosis
• Others

End user (Revenue, USD Million), 2022 – 2033

• Research Laboratories
• Hospitals
• Diagnostic Laboratories
• Others

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA